Navigation Links


Bergman in Medical News

Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics

... Catalyst Biosciences, Inc. Erik Wiberg +1.650.266.8654 ewiberg@catbio.com BCC Partners for Catalyst Biosciences, Inc. Karen L. bergman or Michelle Corral +1.650.575.1509 or +1.415.794.8662 ...

Anixter Center Announces Leadership Changes

... Current President and CEO bergman to depart effective July 3; Board member Krema to ...ter Center president and CEO, announced today that bergman will step down from his position, effective July 3. bergman has served in this role since his appointment foll...

Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products

... Petkus +1.650.266.8654 +1.973.660.5218 ewiberg@catbio.com BCC Partners for Catalyst Biosciences, Inc. Karen L. bergman or Michelle Corral +1.650.575.1509 or +1.415.794.8662 ...

Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO

... Media Inquiries: Matthew Ferguson BCC Partners Chief Financial Officer Karen L. bergman or Michelle Corral 650-266-2825 650-575-1509 or 415-794-8662 investors@proteolix.com ...

Spotlight 29 Casino Laughs It Up With Rita Rudner

...'d never fallen in love. I'd stepped in it a few times. When I eventually met Mr. Right I had no idea that his first name was Always." Rudner and bergman spend their time between their homes in Las Vegas and southern California. "In Hollywood a marriage is a success if it outlasts milk," Rudner has said...

Annual medical ethics conference celebrates 20 years of disputes

...f clinical medical ethics, improved end-of-life care for patients, and new ethical approaches to innovations in surgical can cancer care. The Lindy bergman Distinguished Service Professor of Medicine at the University, Siegler has written and spoken extensively on decision-making in complex medical situat...

Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer

...ences, Inc. Erik Wiberg Chief Financial Officer +1.650.266.8654 ewiberg@catbio.com BCC Partners for Catalyst Biosciences, Inc. Karen L. bergman or Michelle Corral +1.650.575.1509 or +1.415.794.8662 ...

Golden Rainbow Takes a Musical Journey for Its 22nd Annual 'Ribbon of Life' Production Show

...rk that will only be seen during the two days of the fundraising event. All talent in the show donates their time. Sponsors include Paris Las Vegas, bergman Walls & Associates, The Boughner Family Foundation, Century 21 MoneyWorld, David Greenhouse Photography/Liquid Light Studios, Findlay Cadillac Saab, H...

Smile! Make Your New Year's Resolutions a Reality This Year

...ww.pg.com for the latest news and in-depth information about P&G and its brands. For more information: Taryn Levy Kerri bergman 212-891-0404 212-891-0450 tlevy@devries-pr.com kbergman@devries-pr.com ...

Parents: With Halloween Candy, Focus on Choice and Time to Prevent Teeth Decay

... Washington Dental Service website at http://www.DeltaDentalWA.com . Contacts: Sean Pickard (206) 528-2304 spickard@deltadentalwa.com or Paul bergman (206) 528-7346 pbergman@deltadentalwa.com ...
Bergman in Medical Technology

Proteolix, Inc. Drug Candidate, PR-957, Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome

...ct information Media Inquiries: All Other Inquiries: BCC Partners Craig C. Parker Karen L. bergman or Michelle Corral Senior Vice President, Finance and 650-575-1509 or 415-794-8662 Corporate Development & Chief ...

Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting

... information Media Inquiries: All Other Inquiries: BCC Partners Craig C. Parker Karen L. bergman or Michelle Corral Senior Vice President, Finance and Corporate 650-575-1509 or 415-794-8662 ...

Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting

...tact information Media Inquiries: All Other Inquiries: BCC Partners Craig C. Parker Karen L. bergman or Michelle Corral Senior Vice President, Finance and 650-575-1509 or 415-794-8662 Corporate Development & Chief ...

Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology

... Investors: Media Inquiries: Matthew Ferguson BCC Partners Chief Financial Officer Karen L. bergman or Michelle Corral 650-266-2825 650-575-1509 or 415-794-8662 investors@proteolix.com ...

Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia

...com . Catalyst Biosciences, Inc. Erik Wiberg +1.650.266.8654 ewiberg@catbio.com BCC Partners for Catalyst Biosciences, Inc. Karen L. bergman or Michelle Corral +1.650.575.1509 or +1.415.794.8662 ...
Bergman in Biological News

New technique used to profile anthrax genome

... RNA-Seq to any bacterium. In using this approach to study B. anthracis, bergman and colleagues sequenced mRNA samples that were collected from B. anthracis...onal approach to tasks like antibiotic discovery and microbial engineering, bergman noted. "Sequencing-based transcriptome profiling has several huge adva...

Hebrew University scientists reveal mechanism that triggers differentiation of embryo cells

...uctural and Molecular Biology , Professors Yehudit bergman and Howard Cedar of the Hebrew University-Hadassah...lls that can differentiate into specific tissues. bergman is the Morley Goldblatt Professor of Cancer Resear.... Now, with the new information discovered by bergman and Cedar, the molecular program that is responsib...
Bergman in Biological Technology

Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association

...tact information Media Inquiries: All Other Inquiries: BCC Partners Craig C. Parker Karen L. bergman or Michelle Corral Senior Vice President, Finance and 650-575-1509 or 415-794-8662 Corporate Development ...

Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team

... Media Inquiries: Craig C. Parker BCC Partners Senior Vice President, Finance and Karen L. bergman or Michelle Corral Corporate Development & Chief 650-575-1509 or 415-794-8662 Financial Officer 650-266-2682 ...

Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development

... Erik Wiberg Chief Financial Officer +1.650.266.8654 ewiberg@catbio.com BCC Partners for Catalyst Biosciences, Inc. Karen L. bergman or Michelle Corral +1.650.575.1509 or +1.415.794.8662 ...

Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology

... information Investors: Media Inquiries: Matthew Ferguson BCC Partners Chief Financial Officer Karen L. bergman or Michelle Corral 650-266-2825 650-575-1509 or 415-794-8662 investors@proteolix.com ...

Proteolix Presents Preclinical Data for Oral Proteasome Inhibitor PR-047 at the 50th Annual Meeting of the American Society of Hematology

...stors: Media Inquiries: Matthew Ferguson BCC Partners Chief Financial Officer Karen L. bergman or Michelle Corral 650-266-2825 650-575-1509 or 415-794-8662 investors@proteolix.com ...

Orange and Medic4all Launched the World's First Cellular Tele-Health Service

...ttp://www.medic4all.com ) is based in Switzerland and has activities in 28 countries in the world. For further information, please contact Mr. David bergman at info@medic4all.com, +972-3-9226610 ...

Proteolix Raises $79 Million in Series C Financing

...ormation Investors: Media Inquiries: Matthew Ferguson BCC Partners Chief Financial Officer Karen L. bergman or Michelle Corral 650-266-2825 650-575-1509 or 415-794-8662 investors@proteolix.com ...

Taming the anthrax threat

... immune cells able to kill most bacteria. Somehow the bacterium avoids being killed and actually hijacks these phagocytes (microbe-killing cells), bergman says. New drugs, he says, should target the bug during the brief window of vulnerability when the bacteria transform from dormant spores into active, ...

Viragen International's Subsidiary, ViraNative AB, Files to Seek Bankruptcy Protection in Sweden

...le to pay taxes and other debts. The bankruptcy court has appointed Anders bergman of Ackordscentralen Norrland AB as bankruptcy administrator for ViraNative....ess their orderly liquidation and sale in accordance with Swedish laws. Mr. bergman can be reached by telephone at: +46 (0) 90-70 62 00; and by email at: ande...

Taming the anthrax threat

... immune cells able to kill most bacteria. Somehow the bacterium avoids being killed and actually hijacks these phagocytes (microbe-killing cells), bergman says. New drugs, he says, should target the bug during the brief window of vulnerability when the bacteria transform from dormant spores into active, ...
Other TagsHaemostaticBonnVitrectomyGrippingPrechopGillForcep
(Date:11/27/2009)... Multi-purpose bilingual coloring books d...e by the business community to educate - inform pa...from Safety issues to Dinosuars to ABC,S and a hos...t Louis, MO (PRWEB) November 27, 2009 -- Today&rsq...toys to keep them busy any hour of the day, but on...
(Date:11/26/2009)...INCETON, N.J., Nov. 27 The diabete...le over the next 25 years and annual medical spend...n, up from $113 billion today, according to a stud...e . The National Changing Diabetes ® Progra...the analysis by a team from the University of Chic...
(Date:11/26/2009)...r thrill when on an emotional rollercoaster, study...News) -- Call it the fear factor meets the jubilan...ators -- especially those who root for the winning... closely contested match and victory was in doubt,..., Chew on that this Thanksgiving weekend as you,re...
(Date:11/26/2009)... Benton Communications announces a highly...em for retailers struggling to make an economic re...r 26, 2009 -- Flu fears is the type of challenge t...cy room, according to Dr. David Benton, business g...ness growth system – The Rfactor Intensive ...
(Date:11/25/2009)...ERYVILLE, Calif., Nov. 25 /PRNewswire-FirstCall/ -...day announced that the company will host two inves..., December 7, 2009 - 9:00 a.m. CT/10:00 a.m. E...a presentations surrounding carfilzomib in relapse...at the 51st American Society of Hematology (ASH) A...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
(Date:11/25/2009)... Kent State University assistant professors recent...dation (NSF) to continue research beneficial to un...l $890,000. , Christopher Blackwood, assistant p... was awarded grants to support two separate resear...ling Litter Decomposer Communities and Functions f...
(Date:11/24/2009)...entists have crystallised a protein that may help ...he protein could be used by probiotic producers to...nefit to people. , "Probiotics need to interact w...ct, and if they attach to surfaces in the gut they...ert their activity," says Dr Nathalie Juge from th...
(Date:11/24/2009)...ATON ROUGE Antarctica has long held secrets of th...til recently, there has been very little informati...th miles of ice for millions of years. Now, a team...LSU have been funded to the tune of $10 million d... to get to the bottom of things literally. These ...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 26 NTU projects awarded NRF grants 13811 16 NTU projects awarded NRF grants 13811 26 NTU projects awarded NRF grants 13811 36 NTU projects awarded NRF grants 13811 4BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 1BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 2BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 3BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 4Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market 56090 1Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market 56090 2
Other Contentspigmentosumxerodermadiffractiondiffractiondiffractionplugplugplugplugplugyolkyolkyolkfingerfingerfingerfingerfingerfingerfingerzinczinczinczinczinczinc